Phase 1b – Discover Pharma

Welcome to Discover Pharma! Today is : October 20, 2026

Phase 1b

Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Ariadne Bio launches with Parkinson’s apathy drug candidate
Ariadne Bio has launched with funding from The Michael J [...]

September 18, 2026
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Kazia reports 83% response rate for paxalisib in triple-negative breast cancer
Early Phase 1b data show five objective responses among six [...]

September 14, 2026
Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
ProMIS reports no ARIA-E in Phase 1b Alzheimer’s trial of PMN310
ProMIS Neurosciences has reported six-month interim safety and biomarker data [...]

July 29, 2026
Clinical & Regulatory,Drug Discovery & Development,Research & Development,Therapeutic Areas
NEJM study provides first clinical evidence for NET-degrading therapy in lupus
A study published in The New England Journal of Medicine [...]

July 17, 2026
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
Resalis doses first participant in Phase 1b obesity trial
Resalis Therapeutics has dosed the first participant in a Phase [...]

June 30, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK